The in vivo experiments showed that the F4/80+ or CD206+ cells in tumor tissues from mouse xenograft were increased after the subcutaneous injection of the MDA-MB-468 cells which were stably transfected with linc00514-OVE (Fig. 2d). This evidence concerns the gene MRC1 and neoplasm.